LightPath Technologies, Inc. — Form 10-Q Summary
Reporting period: Quarter ended March 31, 2013, the third quarter of fiscal 2013. The request metadata says “2012 Q3,” but the filing covers fiscal 2013 Q3 and the nine months ended March 31, 2013.
Business context
LightPath manufactures precision molded optics, infrared lenses, collimators, GRADIUM glass lenses and optical assemblies for industrial, medical, defense, test and measurement, and telecommunications markets. It operates manufacturing facilities in Orlando and Shanghai. Its strategy includes growing custom design-win and recurring supply business, expanding infrared products, and reducing production costs.
Financial performance
| Metric | Three months ended March 31 | Nine months ended March 31 |
|---|---|---|
| Revenue | $2.85 million, up 3% from $2.78 million | $8.65 million, up 6% from $8.18 million |
| Gross margin | $1.32 million; 47%, versus 32% | $3.77 million; 44%, versus 34% |
| Operating income (loss) | $56,000, versus $(506,000) | $4,000, versus $(1.04) million |
| Net income (loss) | $217,000, or $0.02 per share, versus $(519,000) | $459,000, or $0.04 per share, versus $(1.06) million |
| EBITDA (non-GAAP) | $463,000, versus $(210,000) | $1.16 million, versus $(134,000) |
| Cash flow from operations | Not separately stated for the quarter | $(66,000), versus $97,000 provided |
For the nine months, investing activities used $671,000 and financing activities used $214,000. Cash fell $951,000, from $2.35 million at June 30, 2012 to $1.40 million at March 31, 2013. Capital expenditures were $671,000. Management attributed cash use primarily to investment in production equipment and tooling, working-capital increases, and $180,000 in debenture repayments.
At March 31, 2013, total assets were $8.22 million, current assets $6.13 million, current liabilities $1.72 million, and stockholders’ equity $5.64 million. Accumulated deficit was $204.2 million. The 8% convertible debentures were fully converted or repaid, leaving no debenture balance; remaining reported debt was a $7,804 capital lease obligation. The company had a $599,000 warrant liability. Cash was approximately $1.5 million on April 29, 2013, according to management.
Changes versus the prior comparable period
- Revenue and gross margin improved year over year; precision molded optics unit sales rose 31% in the quarter and 26% for the nine-month period.
- Cost of sales declined, which management linked to lower-cost glass, reduced tooling costs, improved labor productivity, and better absorption of fixed costs.
- The company shifted from losses to reported net income. However, the nine-month improvement includes a $488,000 noncash gain from revaluing warrants; the quarter included a $223,000 gain of this type.
- Cash use increased versus the prior nine-month period, and inventory rose to $1.83 million from $1.51 million at June 30, 2012. Management reported inventory days of cost of sales of 110, versus 75 in the prior-year period.
- Shares outstanding increased to 12.96 million at March 31, 2013 from 11.71 million at June 30, 2012. Debenture conversions, incentive shares, and interest paid in shares contributed to the increase.
Outlook, risks and unusual items
- Management expected operating cash flow to improve in fiscal Q4, citing order bookings, quote activity, a 12-month backlog, and cost-reduction efforts. It anticipated growth in infrared and precision molded optics, and modestly higher new-product-development spending for infrared products.
- Management described markets as weak and uneven, with lower booking rates in the second and third fiscal quarters. It warned that cash resources are limited, no borrowing availability or committed additional financing exists, and external financing may be needed.
- Risks cited include lower sales or slower growth, poor receivable collections, higher material and labor costs, failure to achieve production efficiencies, and discretionary spending. Management noted possible strategic alternatives if financing or cash-flow efforts prove insufficient.
- Backlog was reported at approximately $5.01 million at March 31, 2013. The filing also cites a $623,000 increase but gives an unclear comparison baseline; it separately reports $4.89 million at June 30, 2012.
- A $1.1 million Raytheon development project was recognized using the cost-to-cost method. By March 31, $1.07 million had been recognized as revenue against $743,500 invoiced, with $323,500 recorded as other receivables. Completion was expected by July 2013.
- The company recognized $50,000 of income from an exclusive GRADIUM intellectual-property license; the agreement provides for $150,000 in fees and future royalties beginning in its fourth year. The June 2012 warrants are classified as a liability and remeasured each reporting period, creating earnings volatility.
- The March 2013 early conversion of debentures held largely by directors, officers, and a significant shareholder involved 559,448 incentive shares. The filing states there were no legal proceedings and that disclosure controls were effective.
Important facts for investors to verify
- Whether operating cash flow and cash collections improved after March 31, given the cash decline and management’s dependence on sales growth and working-capital management.
- How much of reported profitability reflects core operations versus warrant fair-value gains and license income.
- Whether the $5.01 million backlog converts to shipments and cash, and clarify the filing’s stated backlog comparison baseline.
- Execution and economics of the Raytheon project, including completion, remaining costs, and collection of the $323,500 receivable.
- Potential dilution from outstanding warrants, options, restricted stock units, and the increased common-share count.
- Whether planned cost reductions, lower-cost materials, and production improvements sustain gross margins without compromising customer demand or delivery.